Transaction details
Seventy BG
RP Group (Ethica Global Investments) acquires 70% of Seventy BG – strengthening its position in aesthetic medicine
Ethica Global Investments, an investment company promoted by Ethica Group, announces that its subsidiary RP Group, active in the production of hyaluronic acid-based medical devices, has finalized the acquisition of 70% of Seventy BG, a company active in the development and distribution of professional medical devices and cosmeceuticals for aesthetic medicine.